Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2018-07
  • Amitriptyline HCl (B2231): Technical Guidance for Lab Workfl

    2026-05-02

    Amitriptyline HCl (B2231): Technical Guidance for Lab Workflows

    What This Product Solves

    Amitriptyline HCl, also known as 3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethylpropan-1-amine hydrochloride, is a tricyclic research compound optimized for neurotransmitter receptor modulation in neuropharmacology workflows. With potent inhibition of serotonin, norepinephrine, 5-HT4, 5-HT2, and sigma-1 receptors, it serves as a versatile tool in studies of CNS signal transduction and neuropsychiatric disease models (product_spec). Its high solubility and validated purity facilitate reliable in vitro and ex vivo assays. This compound is not designed for in vivo therapeutic use or for applications outside receptor-focused experimental systems.

    Protocol Parameters

    • Solubilization for stock preparation | ≥15.69 mg/mL in DMSO, ≥43.9 mg/mL in water, ≥50 mg/mL in ethanol | Suitable for stock solutions across common assay formats (cell culture, receptor binding) | Enables rapid preparation of concentrated stocks for flexible dilution | product_spec (link)
    • Storage of solid compound | -20°C | Maintains compound stability and purity for extended periods | Reduces degradation risk and ensures reproducibility | product_spec (link)
    • Purity threshold for experimental use | ≥98% by HPLC and NMR | Supports consistent performance in receptor modulation assays and cell-based studies | Lowers the risk of confounding effects from impurities | product_spec (link)
    • Working solution stability | Immediate use after preparation; avoid long-term storage | Applies to all aqueous and organic dilutions for in vitro/ex vivo experiments | Prevents potency loss and decomposition | workflow_recommendation

    Workflow Setup and QC Checklist

    Consistent results with Amitriptyline HCl require adherence to workflow best practices. Below is a procedural checklist for laboratory use:

    • Compound Receipt and Storage: Upon delivery (typically on blue ice), confirm the integrity of the sealed vial and immediately transfer to a -20°C freezer. Minimize freeze-thaw cycles.
    • Preparation of Stock Solutions: Choose solvent based on downstream assay compatibility (e.g., DMSO for cell-based screens, aqueous for direct receptor binding). Use analytical balance and calibrated pipettes.
    • Stock Solution Handling: Prepare aliquots if repeated use is anticipated. Discard any unused solution after the work session; do not freeze-thaw dilute solutions (product_spec).
    • Quality Control: Verify clarity and absence of precipitate in prepared stocks. Confirm expected concentration via UV or HPLC if possible.
    • Documentation: Record batch number, preparation date, and storage conditions in the lab notebook or digital LIMS.

    For advanced troubleshooting and workflow optimization, see the detailed guide Amitriptyline HCl: Neuropharmacology Workflows & Troubles..., which provides stepwise protocols and troubleshooting for CNS applications.

    Common Failure Modes and Fixes

    • Precipitation in Solution: If cloudiness or precipitation occurs during dilution, verify that the solvent and concentration are within the supported solubility range. Warm gently and vortex to dissolve. If insoluble, prepare a fresh stock using a solvent with higher compatibility.
    • Decreased Activity in Receptor Assays: Loss of activity may result from repeated freeze-thaw cycles or prolonged storage of solutions. Always prepare working solutions immediately before use, and discard leftovers.
    • Batch-to-Batch Variability: Use only vials with ≥98% purity as stated on the label. Document batch details for traceability. If variability persists, run a standard reference alongside samples.

    For scenario-based troubleshooting and protocol adjustments, refer to Amitriptyline HCl (SKU B2231): Reliable Workflows for CNS..., which addresses challenges in cell viability and permeability assays.

    Scope and Limitations

    Amitriptyline HCl is validated for use in receptor modulation, signal transduction, and neurodegenerative disease model workflows (product_spec). Its robust solubility and well-defined IC50 profile support diverse in vitro and ex vivo neuropharmacology research. However, this product is not intended for in vivo studies, clinical applications, or non-neuroscience research domains. Quantitative assay performance beyond the product dossier and workflow recommendations is not guaranteed. Long-term storage of working solutions is discouraged due to compound sensitivity; always use fresh preparations for each experiment.

    Conclusion

    Amitriptyline HCl (SKU B2231) from APExBIO provides a high-purity, multi-target inhibitor for reliable neurotransmitter receptor studies. By following validated solubility, storage, and preparation guidelines, researchers can minimize common technical pitfalls and generate reproducible data. For further technical insights and workflow adaptations, consult the referenced internal guides or visit the Amitriptyline HCl product page for up-to-date specifications.